Search Within

Anita Kumar

Formats
  1. Meeting Abstract (112)
  2. Journal Article (64)
  3. Review (8)
  4. Book Section (6)
  5. Research Letter (5)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (197)
  2. Department of Medicine (197)
  3. Hematologic Malignancies, Division of (197)
  4. Lymphoma (197)
  5. Survivorship Research (104)
  6. Population Sciences Research Program (103)

More Groups

People
  1. Andrew Zelenetz (136)
  2. Paul Hamlin (107)
  3. Alison Moskowitz (105)
  4. Ariela Noy (105)
  5. Maria Palomba (100)
  6. Steven Horwitz (98)

More People

Years
  1. 2025 (7)
  2. 2024 (33)
  3. 2023 (32)
  4. 2022 (12)
  5. 2021 (24)
  6. 2020 (17)

More Years

Publications
  1. Blood (84)
  2. Hematological Oncology (19)
  3. Journal of Clinical Oncology (13)
  4. Blood Advances (11)
  5. Haematologica (9)
  6. Leukemia and Lymphoma (8)

More Publications

Publishers
  1. American Society of Hematology (96)
  2. Wiley Blackwell (19)
  3. American Society of Clinical Oncology (13)
  4. Nature Publishing Group (10)
  5. Ferrata Storti Foundation (9)
  6. Taylor & Francis Group (9)

More Publishers

Results (197)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
    Meeting Abstract

    Moskowitz, A. J.; Schòˆder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD chemotherapy followed by ISRT: A safe primary treatment regimen for early-stage, unfavorable Hodgkin lymphoma
    Meeting Abstract

    Yang, J. C.; Kumar, A.; Chapman, K. L.; Constine, L. S.; Moskowitz, C. H.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • The emerging role of checkpoint inhibitor therapy in Hodgkin lymphoma
    Journal Article

    Kumar, A.
    Oncology (Norwalk) (2016)

    Fulltext@MSK | Save
  • Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: Prognostic significance of measurements in the coronal and transverse planes
    Journal Article

    Kumar, A.; Burger, I. A.; Zhang, Z.; Drill, E. N.; Migliacci, J. C.; Ng, A.; LaCasce, A.; Wall, D.; Witzig, T. E.; Ristow, K.; more...
    Haematologica (2016)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schòˆder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • A unique variant of indolent mantle cell lymphoma exclusively involving gastrointestinal tract
    Meeting Abstract

    Sae-Ow, W.; Pichardo, J.; Ying, Z.; Kumar, A.; Zelenetz, A. D.; Younes, A.; Dogan, A.
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • A unique variant of indolent mantle cell lymphoma exclusively involving gastrointestinal tract
    Meeting Abstract

    Sae-Ow, W.; Pichardo, J.; Ying, Z.; Kumar, A.; Zelenetz, A. D.; Younes, A.; Dogan, A.
    Laboratory Investigation (2016)

    Fulltext@MSK | Save
  • Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
    Meeting Abstract

    Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Targeting CD30 in patients with Hodgkin lymphoma
    Book Section

    Kumar, A.; Pileri, S.; Younes, A.; Engert, A.
    In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

    Fulltext@MSK | Save
  • Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era
    Journal Article

    Kumar, A.; Lunning, M. A.; Zhang, Z.; Migliacci, J. C.; Moskowitz, C. H.; Zelenetz, A. D.
    British Journal of Haematology (2015)

    Fulltext@MSK | Save